Financial writer discusses Coya Therapeutics, Inc.'s Treg therapies for neurodegenerative diseases like ALS, FTD, and PD.

GENFI Top Hits. CSF proteomics linked abundance of CALB2, GRN/NAGA, and PEA15/SEMA6A to C9ORF72 (gold), GRN (red), and MAPT ...

Frontotemporal dementia is associated with a wide variety of abnormal eating behaviours such as hyperphagia, fixations on one ...

A major trial in frontotemporal dementia patients has found that oxytocin can help improve symptoms of apathy. A new study ...

Have you ever noticed subtle changes in a loved one's personality or behavior and wondered if it's more than just aging?

Fast Track Designation highlights potential of amezalpat to address unmet need for patients with HCC. Amezalpat builds momentum with both Fast Track and Orphan Drug Designations.

Furthermore, there is a strong link with motor neuron disease; 15% of patients with FTD develop amyotrophic lateral sclerosis (ALS). Conversely, many patients with ALS develop frontal executive ...

Wendy Williams should undergo more medical testing, her guardian said, following the former host's bombshell "Breakfast Club" ...

The documentary "Susan" follows a woman living with frontotemporal dementia and her advocacy for others with the disease, ...

The FDA granted fast track designation to 64Cu-SAR-bisPSMA for PET imaging of PSMA-positive prostate cancer lesions in ...

A new study led by Western researchers found frequent treatment with intranasal oxytocin – a hormone in the brain associated ...